Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
MOBIUS PBC, commonly known as MOBIUS, is a pioneering US-headquartered biotechnology firm established in 2021. Operating within the Research and Development in Biotechnology sector (excluding Nanobiotechnology), MOBIUS is at the forefront of regenerative medicine, focusing on critical unmet medical needs.
This innovative Public Benefit Corporation is dedicated to developing novel cell and organ manufacturing technologies. MOBIUS PBC's unique approach aims to accelerate the ethical clinical translation of advanced therapies, addressing the global shortage of viable organs for transplant.
Positioned as an innovator, MOBIUS PBC is leading the way in bioengineering solutions, transforming scientific discoveries into tangible clinical impacts. Their commitment to public benefit underpins their mission to revolutionise healthcare.
-9 vs industry average
MOBIUS PBC’s score of 18 is lower than 45% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research and Development in Biotechnology (except Nanobiotechnology) has below-average carbon intensity
The Research and Development in Biotechnology (except Nanobiotechnology) industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for MOBIUS PBC yet.
MOBIUS PBC, a US-based company operating in Research and Development in Biotechnology, does not publicly report its carbon emissions data. Therefore, specific figures for Scope 1, Scope 2, or Scope 3 emissions cannot be provided. The company has not disclosed any specific reduction targets or climate commitments, including Science Based Targets (SBTi) or a Climate Pledge.
No climate goals have been disclosed for MOBIUS PBC yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more